Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Acceleron Pharma Inc. (XLRN)

« Back to company index

XLRN Chatter Timeline

Stock Ticker for XLRN

Most Active Tweeters for XLRN

UserTweets
@Tickeron 12
@gcassidy718 5
@ConsumerFeed 3
@AmericanBanking 3
@bbnsnews 2

Recent Tweets for XLRN

Tickeron @Tickeron
$XLRN's 10-day Moving Average broke below its 50-day Moving Average on September 25, 2019. View odds for this and o… https://t.co/pRwRp27csz
October 21st 2019, 2:10pm
Quantumup1 @Quantumup1
$XLRN kept at an Overweight rating, $71 PT at Piper Jaffray https://t.co/yKxjxzjDgh
October 21st 2019, 7:10am
macondailynews @macondailynews
Acceleron Pharma $XLRN Upgraded to Hold at BidaskClub https://t.co/SjGY2pUhni
October 21st 2019, 6:10am
gcassidy718 @gcassidy718
$XLRN buyer at $46.37 -2.54 % change recently https://t.co/Cjbv1BHC3y
October 21st 2019, 2:10am
Forex4News @Forex4News
RT @Tickeron: $XLRN's 10-day Moving Average broke below its 50-day Moving Average on September 25, 2019. View odds for this and other indic…
October 20th 2019, 2:10pm
Tickeron @Tickeron
$XLRN's 10-day Moving Average broke below its 50-day Moving Average on September 25, 2019. View odds for this and o… https://t.co/VhAu6Mx4pu
October 20th 2019, 2:10pm
ConsumerFeed @ConsumerFeed
Acceleron Pharma $XLRN Rating Increased to Hold at BidaskClub https://t.co/RovSiCkBF2
October 20th 2019, 7:10am
bbnsnews @bbnsnews
Acceleron Pharma $XLRN Rating Increased to Hold at BidaskClub https://t.co/WTAwmr7CtM
October 20th 2019, 7:10am
Tickeron @Tickeron
$XLRN's 10-day Moving Average moved below its 50-day Moving Average on September 25, 2019. View odds for this and o… https://t.co/QQnYxY4N5X
October 19th 2019, 5:10pm
stocknewstimes @stocknewstimes
Acceleron Pharma $XLRN Upgraded to Hold by BidaskClub https://t.co/h9jjgR5zSj
October 19th 2019, 4:10pm
TranscriptDaily @TranscriptDaily
Acceleron Pharma $XLRN Upgraded to Hold by BidaskClub https://t.co/6XdFqDSlsq
October 19th 2019, 4:10pm
TradeTexasBig @TradeTexasBig
$XLRN weekly is good . tomorrows close important.
October 17th 2019, 6:10pm
Tickeron @Tickeron
$XLRN in Uptrend: Stochastic indicator driving into overbought zone. View odds for this and other indicators:… https://t.co/JayJ2rjr5q
October 17th 2019, 4:10pm
SwingTradeBot @SwingTradeBot
Rose Above 50 DMA today: $CME $XLRN ... https://t.co/qwiJH6vr1O
October 17th 2019, 3:10pm
Tickeron @Tickeron
$XLRN's 10-day Moving Average broke below its 50-day Moving Average on September 25, 2019. View odds for this and o… https://t.co/DMwUN3C1ed
October 16th 2019, 4:10pm
TickerReport @TickerReport
Cowen Reaffirms “Buy” Rating for Acceleron Pharma $XLRN https://t.co/v42ABveM9X
October 16th 2019, 3:10am
ConsumerFeed @ConsumerFeed
Cowen Reaffirms “Buy” Rating for Acceleron Pharma $XLRN https://t.co/7mqTMudm1s
October 16th 2019, 3:10am
TranscriptDaily @TranscriptDaily
Acceleron Pharma Inc $XLRN Receives $59.36 Average Price Target from Brokerages https://t.co/WJll3u5lCH
October 15th 2019, 10:10pm
gcassidy718 @gcassidy718
$XLRN major quote changes  3.40 % https://t.co/Cjbv1BHC3y
October 15th 2019, 5:10pm
Tickeron @Tickeron
$XLRN's 10-day Moving Average moved below its 50-day Moving Average on September 25, 2019. View odds for this and o… https://t.co/blOrr8K8SC
October 15th 2019, 3:10pm
macondailynews @macondailynews
Morgan Stanley Lowers Acceleron Pharma $XLRN Price Target to $48.00 https://t.co/tOMhUzrO41
October 15th 2019, 4:10am
ThisLincolnian @ThisLincolnian
Acceleron Pharma $XLRN Rating Reiterated by Cowen https://t.co/mXvvwe16L2
October 15th 2019, 4:10am
Tickeron @Tickeron
$XLRN's 10-day Moving Average moved below its 50-day Moving Average on September 25, 2019. View odds for this and o… https://t.co/4tF0tk3SGy
October 14th 2019, 3:10pm
gcassidy718 @gcassidy718
$XLRN Do we see $44.66 next?  2.86 % change recently https://t.co/Cjbv1BHC3y
October 14th 2019, 2:10pm
Tickeron @Tickeron
$XLRN's 10-day Moving Average broke below its 50-day Moving Average on September 25, 2019. View odds for this and o… https://t.co/Dmvcdqz04s
October 14th 2019, 12:10am
semodough @semodough
$XLRN Catalysts Topline luspatercept Phase 2 data in MF (2H19) Preliminary ACE-083 Phase 2 Part 2 data CMT (1Q20) P… https://t.co/dAwlNil7wP
October 13th 2019, 10:10pm
AmericanBanking @AmericanBanking
Acceleron Pharma’s $XLRN “Buy” Rating Reiterated at Cowen https://t.co/JpWoDw93s8 #stocks
October 13th 2019, 9:10pm
ConsumerFeed @ConsumerFeed
Morgan Stanley Lowers Acceleron Pharma $XLRN Price Target to $48.00 https://t.co/r0BWzw6IuN
October 13th 2019, 9:10am
BlueBioNow @BlueBioNow
$XLRN "Everything is impossible until someone does it" 2.87 % change recently https://t.co/gR0MpM5fid
October 13th 2019, 7:10am
Tickeron @Tickeron
$XLRN's 10-day Moving Average crossed below its 50-day Moving Average on September 25, 2019. View odds for this and… https://t.co/xDxAQCU4y5
October 12th 2019, 8:10pm
bbnsnews @bbnsnews
Acceleron Pharma Inc $XLRN Expected to Post Quarterly Sales of $3.45 Million https://t.co/0jP5LiVCZH
October 12th 2019, 8:10pm
ZolmaxNews @ZolmaxNews
Acceleron Pharma $XLRN Price Target Cut to $48.00 by Analysts at Morgan Stanley https://t.co/AoWLYSSrpb
October 12th 2019, 1:10pm
WeekHerald @WeekHerald
-$0.81 Earnings Per Share Expected for Acceleron Pharma Inc $XLRN This Quarter https://t.co/qWltNNAkGE
October 12th 2019, 12:10pm
OlympiaReport @OlympiaReport
Analysts Anticipate Acceleron Pharma Inc $XLRN to Announce -$0.81 EPS https://t.co/r6HsXzxlqP
October 12th 2019, 10:10am
ThisLincolnian @ThisLincolnian
Analysts Anticipate Acceleron Pharma Inc $XLRN to Announce -$0.81 EPS https://t.co/j3Tu2k1Ttw
October 12th 2019, 10:10am
gcassidy718 @gcassidy718
$XLRN The Broad market is turning Green .. Big Green Reversal coming? 2.14 % change recently https://t.co/Cjbv1BHC3y
October 12th 2019, 3:10am
1MinuteStock @1MinuteStock
Do you know that #WallStreet price for $XLRN is $58.92 https://t.co/kZs85uRxwu
October 11th 2019, 10:10pm
AmericanBanking @AmericanBanking
Morgan Stanley Lowers Acceleron Pharma $XLRN Price Target to $48.00 https://t.co/y992WyF0CD #stocks
October 11th 2019, 2:10pm
haodongvli @haodongvli
$XLRN adding for Dec 2019 and April 2020 FDA approval
October 11th 2019, 10:10am
tradersreport @tradersreport
RT @Tickeron: $XLRN in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators: https://t.co/Ij2tQqEEWg #Accele…
October 10th 2019, 5:10pm
Tickeron @Tickeron
$XLRN in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/Pwy45gXB4S
October 10th 2019, 5:10pm
ChartMill @ChartMill
$XLRN has a Quick Ratio of 17.11, indicating it is financially healthy. https://t.co/j5i3M5uBrL https://t.co/jffIMOGJh5
October 10th 2019, 5:10am
Tickeron @Tickeron
$XLRN in Uptrend: 50-day Moving Average moved above 200-day Moving Average on September 10, 2019. View odds for thi… https://t.co/6KkAatmq3F
October 9th 2019, 4:10pm
TickerReport @TickerReport
Brokerages Expect Acceleron Pharma Inc $XLRN to Announce -$0.81 EPS https://t.co/27M0gRM53W
October 9th 2019, 8:10am
ledgerzette @ledgerzette
Analysts Anticipate Acceleron Pharma Inc $XLRN to Post -$0.81 EPS https://t.co/gvpiWt0TJm #stocks
October 9th 2019, 7:10am
intercooleronli @intercooleronli
Analysts Anticipate Acceleron Pharma Inc $XLRN to Post -$0.81 EPS https://t.co/MjJenzJngm #investingnews
October 9th 2019, 7:10am
gcassidy718 @gcassidy718
$XLRN I am gona keep buying until it hits $44.51 dollars -2.15 % change https://t.co/Cjbv1BHC3y
October 9th 2019, 2:10am
Tickeron @Tickeron
$XLRN's 10-day Moving Average broke below its 50-day Moving Average on September 25, 2019. View odds for this and o… https://t.co/z3YXPVZEee
October 8th 2019, 3:10pm
AmericanBanking @AmericanBanking
Acceleron Pharma Inc $XLRN Receives Consensus Rating of “Buy” from Brokerages https://t.co/bWT7l6aJ4n #stocks
October 8th 2019, 6:10am
BlueBioNow @BlueBioNow
$XLRN I'll have my bear burger medium rare with mushroom and swiss please. 2.39 % change recently https://t.co/gR0MpM5fid
October 7th 2019, 7:10pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.